<DOC>
	<DOC>NCT01672047</DOC>
	<brief_summary>The investigators hypothesize that the chronic kidney disease patients who suffer from vitamin D deficiency will be benefit from given Vitamin D2 because coronary artery calcification and hyperparathyroidism will be improved.</brief_summary>
	<brief_title>Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients</brief_title>
	<detailed_description>We will call for 350 CKD patients (250 CKD3-5stage and 100 CKD5D stage)who suffer from vitamin D deficiency.They will be divided into 2 groups. One group will be given vitamin D and the other will not. They will take coronary artery CT test every year(in 2 years).We will compare the coronary calcification progression between the 2 groups.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>chronic kidney disease patients (35D) serum 25（OH）D &lt; 40nmol/L(16ng/ml)，serum calcium &lt; 2.55mmol/L（10.2mg/dL）； willing to sign could obey the follow up design allergy to vitamin D heart failure (NYHA more than 2 grade) pregnant malignant tumor critical hepatic disease taking Vitamin D or analogue in 3 recent months taking other clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>The 25(OH) vitamin D level</keyword>
	<keyword>The 1.25(OH) vitamin D level</keyword>
	<keyword>The intact PTH level</keyword>
	<keyword>The calcification score of coronary artery</keyword>
	<keyword>The microalbuminuria level</keyword>
</DOC>